| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1036950393 |
| P356 | DOI | 10.1186/1742-2094-11-119 |
| P932 | PMC publication ID | 4096420 |
| P698 | PubMed publication ID | 24996486 |
| P5875 | ResearchGate publication ID | 263743381 |
| P50 | author | Krista L Lanctôt | Q42725631 |
| Paul Oh | Q62595726 | ||
| Daniel Figeys | Q63955330 | ||
| P2093 | author name string | Nathan Herrmann | |
| Steffany A L Bennett | |||
| Hongbin Xu | |||
| Graham Mazereeuw | |||
| P2860 | cites work | A rating scale for depression | Q24564540 |
| A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION | Q25939000 | ||
| The relationship between executive function and falls and gait abnormalities in older adults: a systematic review | Q26829189 | ||
| Targeted lipidomics - advances in profiling lysophosphocholine and platelet-activating factor second messengers | Q27008183 | ||
| The vascular depression hypothesis: mechanisms linking vascular disease with depression | Q27010321 | ||
| A meta-analysis of depression severity and cognitive function | Q28244381 | ||
| Using neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer's Disease. | Q30451918 | ||
| Risk factors for late-life cognitive decline and variation with age and sex in the Sydney Memory and Ageing Study | Q31120480 | ||
| Coronary heart disease is associated with non-amnestic mild cognitive impairment | Q33926616 | ||
| National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards | Q33998646 | ||
| Coronary artery disease is associated with cognitive decline independent of changes on magnetic resonance imaging in cognitively normal elderly adults | Q35827883 | ||
| The relationship between subtypes of depression and cardiovascular disease: a systematic review of biological models | Q35844284 | ||
| Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study | Q36399638 | ||
| Factors associated with adherence to medication regimens in older primary care patients: the Steel Valley Seniors Survey. | Q37174287 | ||
| Amyloid-beta42 signals tau hyperphosphorylation and compromises neuronal viability by disrupting alkylacylglycerophosphocholine metabolism. | Q37469703 | ||
| Lipid classification, structures and tools | Q37715815 | ||
| Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease | Q37779106 | ||
| Lipidomics era: accomplishments and challenges. | Q37798778 | ||
| Managing cognitive dysfunction through the continuum of Alzheimer's disease: role of pharmacotherapy | Q37842435 | ||
| A topographical map of the causal network of mechanisms underlying the relationship between major depressive disorder and coronary heart disease. | Q37866294 | ||
| The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications | Q38004705 | ||
| Cardiac disease and cognitive impairment: a systematic review | Q38018018 | ||
| Depression as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies | Q38027800 | ||
| Platelet activating factors in depression and coronary artery disease: a potential biomarker related to inflammatory mechanisms and neurodegeneration. | Q38117027 | ||
| Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons | Q39972669 | ||
| A dynamic view of depressive symptoms and neurocognitive change among patients with coronary artery disease | Q40024983 | ||
| Visualization and Phospholipid Identification (VaLID): online integrated search engine capable of identifying and visualizing glycerophospholipids with given mass. | Q42754093 | ||
| Efficacy and tolerability of antidepressants for treatment of depression in coronary artery disease: a meta-analysis | Q43151256 | ||
| The association between depressive symptoms, cognitive function, and inflammation in major depression | Q44395463 | ||
| Neuropsychological measures in normal individuals that predict subsequent cognitive decline. | Q45950998 | ||
| Verbal memory performance and completion of cardiac rehabilitation in patients with coronary artery disease | Q46167356 | ||
| Identification and quantitation of changes in the platelet activating factor family of glycerophospholipids over the course of neuronal differentiation by high-performance liquid chromatography electrospray ionization tandem mass spectrometry. | Q46941327 | ||
| Executive dysfunction, awareness deficits and quality of life in patients with cerebral small vessel disease: a structural equation model | Q48129470 | ||
| The vascular depression hypothesis: 10 years later | Q48343091 | ||
| Cognitive impairment and risk of cardiovascular events and mortality | Q48687138 | ||
| Treatment response and cognitive impairment in major depression: association with C-reactive protein | Q48950624 | ||
| Interleukin-6 and verbal memory in recurrent major depressive disorder. | Q50994689 | ||
| Interaction of atherosclerosis and inflammation in elderly subjects with poor cognitive function. | Q51944567 | ||
| Glycerophosphocholine molecular species profiling in the biological tissue using UPLC/MS/MS | Q84434070 | ||
| P921 | main subject | coronary artery disease | Q844935 |
| P304 | page(s) | 119 | |
| P577 | publication date | 2014-07-04 | |
| P1433 | published in | Journal of Neuroinflammation | Q15716679 |
| P1476 | title | Platelet-activating factors are associated with cognitive deficits in depressed coronary artery disease patients: a hypothesis-generating study | |
| P478 | volume | 11 |
| Q58692465 | Cognitive function in patients with coronary artery disease: A literature review |
| Q50175494 | Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target. |
| Q46247864 | Oligomeric and fibrillar amyloid beta 42 induce platelet aggregation partially through GPVI. |
| Q36052368 | Platelet activating factors are associated with depressive symptoms in coronary artery disease patients: a hypothesis-generating study |
| Q38591116 | Recent advances in lipidomics for disease research |
Search more.